新型コロナウイルス感染症の影響によるヒト胚性幹細胞の世界市場2020-2026:用途別(再生医療、幹細胞生物研究、組織・毒性試験)、地域別

◆英語タイトル:Global Human Embryonic Stem Cells Market Size study with COVID-19 Impact, by Application (Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing), and Regional Forecasts 2020-2026
◆商品コード:BZW20JN001
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2020年5月25日
◆ページ数:約200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥514,800見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥650,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、新型コロナウイルス感染症の影響によるヒト胚性幹細胞の世界市場について調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、用途別(再生医療、幹細胞生物研究、組織・毒性試験)分析、地域別分析、競争状況などを含め、次の構成でお届け致します。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・新型コロナウイルス感染症の影響によるヒト胚性幹細胞の世界市場:用途別(再生医療、幹細胞生物研究、組織・毒性試験)
・新型コロナウイルス感染症の影響によるヒト胚性幹細胞の世界市場:地域別
・競争状況
【レポートの概要】

Global Human Embryonic Stem Cells Market is valued approximately USD XX billion in 2019 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2020-2026. Due to COVID-19 pandemic, the market is facing challenges because of government protocols to stay at home across the world. Human Embryonic Stem Cells (hESCs) are derived from blastocyst and are capable of differentiating into number of cell types that make up the human body as well as it replicates indefinitely and produce non-regenerative tissues such as neural and myocardial cells. They are used in treating a number of blood and genetic disorders related to the immune system, cancers, and disorders as well as used in investigational studies of early human development, genetic diseases and toxicology testing. The technological advancement involving stem cells therapy, rising demand for regenerative medicines, R&D in toxicology testing, technological advancements for the production of embryonic stem cells through alternative methods and increasing prevalence of genetic disorders are the few factors responsible for growth of the market over the forecast period. Furthermore, the introduction of innovative products and other strategic advancements by market players will create lucrative opportunities for the market. For instance, as per company’s news release in January 2019, Stemcell Technologies Inc. launched mTeSR™ Plus, an enhanced version of mTeSR™1. mTeSR™ Plus is the stabilized feeder-free maintenance medium for human embryonic stem (ES) and induced pluripotent stem (iPS) cells. However, ethical concern related to stem cell research is the major factor restraining the growth of global Vegetable Chips market during the forecast period.

The regional analysis of global Human Embryonic Stem Cells market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Asia Pacific is the leading/significant region across the world due to the presence of several prominent entities incorporated in the U.S. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026.

Major market player included in this report are:
Astellas Pharma Inc/ Ocata Therapeutics
Stemcell Technologies Inc.
Biotime, Inc. / Cell Cure Neurosciences LTD
Thermo Fisher Scientific, Inc.
CellGenix GmbH
ESI BIO
PromoCell GmbH
Lonza Group AG
Kite Pharma
Cynata Therapeutics Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Application:
Regenerative Medicine
Stem Cell Biology Research
Tissue Engineering
Toxicology Testing

By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017, 2018
Base year – 2019
Forecast period – 2020 to 2026

Target Audience of the Global Human Embryonic Stem Cells Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)
1.2.1. Human Embryonic Stem Cells Market, by Region, 2018-2026 (USD Billion)
1.2.2. Human Embryonic Stem Cells Market, by Application, 2018-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Human Embryonic Stem Cells Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Human Embryonic Stem Cells Market Dynamics
3.1. Human Embryonic Stem Cells Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Human Embryonic Stem Cells Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Human Embryonic Stem Cells Market, by Application
5.1. Market Snapshot
5.2. Global Human Embryonic Stem Cells Market by Application, Performance – Potential Analysis
5.3. Global Human Embryonic Stem Cells Market Estimates & Forecasts by Application 2016-2026 (USD Billion)
5.4. Human Embryonic Stem Cells Market, Sub Segment Analysis
5.4.1. Regenerative Medicine
5.4.2. Stem Cell Biology Research
5.4.3. Tissue Engineering
5.4.4. Toxicology Testing
Chapter 6. Global Human Embryonic Stem Cells Market, Regional Analysis
6.1. Human Embryonic Stem Cells Market, Regional Market Snapshot
6.2. North America Human Embryonic Stem Cells Market
6.2.1. U.S. Human Embryonic Stem Cells Market
6.2.1.1. Application breakdown estimates & forecasts, 2016-2026
6.2.2. Canada Human Embryonic Stem Cells Market
6.3. Europe Human Embryonic Stem Cells Market Snapshot
6.3.1. U.K. Human Embryonic Stem Cells Market
6.3.2. Germany Human Embryonic Stem Cells Market
6.3.3. Rest of Europe Human Embryonic Stem Cells Market
6.4. Asia-Pacific Human Embryonic Stem Cells Market Snapshot
6.4.1. China Human Embryonic Stem Cells Market
6.4.2. India Human Embryonic Stem Cells Market
6.4.3. Japan Human Embryonic Stem Cells Market
6.4.4. Rest of Asia Pacific Human Embryonic Stem Cells Market
6.5. Latin America Human Embryonic Stem Cells Market Snapshot
6.5.1. Brazil Human Embryonic Stem Cells Market
6.5.2. Mexico Human Embryonic Stem Cells Market
6.6. Rest of The World Human Embryonic Stem Cells Market

Chapter 7. Competitive Intelligence
7.1. Top Market Strategies
7.2. Company Profiles
7.2.1. Astellas Pharma Inc/ Ocata Therapeutics
7.2.1.1. Key Information
7.2.1.2. Overview
7.2.1.3. Financial (Subject to Data Availability)
7.2.1.4. Product Summary
7.2.1.5. Recent Developments
7.2.2. Stemcell Technologies Inc.
7.2.3. Biotime, Inc. / Cell Cure Neurosciences LTD
7.2.4. Thermo Fisher Scientific, Inc.
7.2.5. CellGenix GmbH
7.2.6. ESI BIO
7.2.7. PromoCell GmbH
7.2.8. Lonza Group AG
7.2.9. Kite Pharma
7.2.10. Cynata Therapeutics Ltd
Chapter 8. Research Process
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes
8.3. Research Assumption

TABLE 1. List of secondary sources, used in the study of global Human Embryonic Stem Cells market
TABLE 2. List of primary sources, used in the study of global Human Embryonic Stem Cells market
TABLE 3. Global Human Embryonic Stem Cells market, report scope
TABLE 4. Years considered for the study
TABLE 5. Exchange rates considered
TABLE 6. Global Human Embryonic Stem Cells market estimates & forecasts by region 2016-2026 (USD Billion)
TABLE 7. Global Human Embryonic Stem Cells market estimates & forecasts by Application 2016-2026 (USD Billion)
TABLE 8. Global Human Embryonic Stem Cells market by segment, estimates & forecasts, 2016-2026 (USD Billion)
TABLE 9. Global Human Embryonic Stem Cells market by region, estimates & forecasts, 2016-2026 (USD Billion)
TABLE 10. Global Human Embryonic Stem Cells market by segment, estimates & forecasts, 2016-2026 (USD Billion)
TABLE 11. Global Human Embryonic Stem Cells market by region, estimates & forecasts, 2016-2026 (USD Billion)
TABLE 12. Global Human Embryonic Stem Cells market by segment, estimates & forecasts, 2016-2026 (USD Billion)
TABLE 13. Global Human Embryonic Stem Cells market by region, estimates & forecasts, 2016-2026 (USD Billion)
TABLE 14. Global Human Embryonic Stem Cells market by segment, estimates & forecasts, 2016-2026 (USD Billion)
TABLE 15. Global Human Embryonic Stem Cells market by region, estimates & forecasts, 2016-2026 (USD Billion)
TABLE 16. U.s. Human Embryonic Stem Cells market estimates & forecasts, 2016-2026 (USD Billion)
TABLE 17. U.s. Human Embryonic Stem Cells market estimates & forecasts by segment 2016-2026 (USD Billion)
TABLE 18. Canada Human Embryonic Stem Cells market estimates & forecasts, 2016-2026 (USD Billion)
TABLE 19. Canada Human Embryonic Stem Cells market estimates & forecasts by segment 2016-2026 (USD Billion)
TABLE 20. Uk Human Embryonic Stem Cells market estimates & forecasts, 2016-2026 (USD Billion)
TABLE 21. Uk Human Embryonic Stem Cells market estimates & forecasts by segment 2016-2026 (USD Billion)
TABLE 22. Germany Human Embryonic Stem Cells market estimates & forecasts, 2016-2026 (USD Billion)
TABLE 23. Germany Human Embryonic Stem Cells market estimates & forecasts by segment 2016-2026 (USD Billion)
TABLE 24. Roe Human Embryonic Stem Cells market estimates & forecasts, 2016-2026 (USD Billion)
TABLE 25. Roe Human Embryonic Stem Cells market estimates & forecasts by segment 2016-2026 (USD Billion)
TABLE 26. China Human Embryonic Stem Cells market estimates & forecasts, 2016-2026 (USD Billion)
TABLE 27. China Human Embryonic Stem Cells market estimates & forecasts by segment 2016-2026 (USD Billion)
TABLE 28. India Human Embryonic Stem Cells market estimates & forecasts, 2016-2026 (USD Billion)
TABLE 29. India Human Embryonic Stem Cells market estimates & forecasts by segment 2016-2026 (USD Billion)
TABLE 30. Japan Human Embryonic Stem Cells market estimates & forecasts, 2016-2026 (USD Billion)
TABLE 31. Japan Human Embryonic Stem Cells market estimates & forecasts by segment 2016-2026 (USD Billion)
TABLE 32. Roapac Human Embryonic Stem Cells market estimates & forecasts, 2016-2026 (USD Billion)
TABLE 33. Roapac Human Embryonic Stem Cells market estimates & forecasts by segment 2016-2026 (USD Billion)
TABLE 34. Brazil Human Embryonic Stem Cells market estimates & forecasts, 2016-2026 (USD Billion)
TABLE 35. Brazil Human Embryonic Stem Cells market estimates & forecasts by segment 2016-2026 (USD Billion)
TABLE 36. Mexico Human Embryonic Stem Cells market estimates & forecasts, 2016-2026 (USD Billion)
TABLE 37. Mexico Human Embryonic Stem Cells market estimates & forecasts by segment 2016-2026 (USD Billion)
TABLE 38. Rola Human Embryonic Stem Cells market estimates & forecasts, 2016-2026 (USD Billion)
TABLE 39. Rola Human Embryonic Stem Cells market estimates & forecasts by segment 2016-2026 (USD Billion)
TABLE 40. Row Human Embryonic Stem Cells market estimates & forecasts, 2016-2026 (USD Billion)
TABLE 41. Row Human Embryonic Stem Cells market estimates & forecasts by segment 2016-2026 (USD Billion)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[新型コロナウイルス感染症の影響によるヒト胚性幹細胞の世界市場2020-2026:用途別(再生医療、幹細胞生物研究、組織・毒性試験)、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆